Literature DB >> 7576990

p21ras: an oncoprotein functioning in growth factor-induced signal transduction.

J L Bos1.   

Abstract

p21ras is a small GTPase that functions as a molecular switch in intracellular signal transduction pathways activated by a large variety of growth factors. In 50% of colorectal tumours, one of the genes for p21ras is mutated resulting in a constitutive active protein. Recently, progress has been made in the elucidation of the signalling pathways in which p21ras is involved. After a ligand binds to growth factor receptors, in particular receptor tyrosine kinases, a guanine nucleotide exchange factor is activated, which results in p21ras in the GTP-bound form. This GTP-bound form of p21ras interacts with the protein kinase raf1 and induces the activation of a kinase cascade, resulting in various cellular responses. This kinase cascade is part of an integrated network of both positive and negative signalling events.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576990     DOI: 10.1016/0959-8049(95)00168-i

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Sodium salicylate inhibits proliferation and induces G1 cell cycle arrest in human pancreatic cancer cell lines.

Authors:  R A Perugini; T P McDade; F J Vittimberga; A J Duffy; M P Callery
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

2.  Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta.

Authors:  S Kampfer; K Hellbert; A Villunger; W Doppler; G Baier; H H Grunicke; F Uberall
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

3.  Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.

Authors:  Geert J P L Kops; Rene H Medema; Janet Glassford; Marieke A G Essers; Pascale F Dijkers; Paul J Coffer; Eric W-F Lam; Boudewijn M T Burgering
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S.

Authors:  E M McGuffie; D W Frank; T S Vincent; J C Olson
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling.

Authors:  Shiri Kfir; Marcelo Ehrlich; Ayelet Goldshmid; Xuedong Liu; Yoel Kloog; Yoav I Henis
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Spatiotemporal organization of Ras signaling: rasosomes and the galectin switch.

Authors:  Uri Ashery; Ofer Yizhar; Barak Rotblat; Galit Elad-Sfadia; Batya Barkan; Roni Haklai; Yoel Kloog
Journal:  Cell Mol Neurobiol       Date:  2006-05-12       Impact factor: 5.046

7.  A unique platform for H-Ras signaling involving clathrin-independent endocytosis.

Authors:  Natalie Porat-Shliom; Yoel Kloog; Julie G Donaldson
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

8.  Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras.

Authors:  Ruby Shalom-Feuerstein; Ran Levy; Victoria Makovski; Avraham Raz; Yoel Kloog
Journal:  Biochim Biophys Acta       Date:  2008-03-25

9.  Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy.

Authors:  W Giaretti; R Monaco; N Pujic; A Rapallo; S Nigro; E Geido
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

10.  Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation.

Authors:  W Giaretti; A Rapallo; E Geido; A Sciutto; F Merlo; M Risio; F P Rossini
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.